source
- STAT+: At a time of tumult at FDA, a former commissioner is hopeful it’s on a better pathWith the FDA facing upheaval and personnel exits, former commissioner David Kessler sees an opportunity whereby the agency can make a turn for the better.STAT · 2mo ago↗ source
- STAT+: TrumpRx adds generic drugsA deal with Mark Cuban, Amazon Pharmacy, and GoodRx is boosting TrumpRx's offerings.STAT · 2mo ago↗ source
- BioMarin drug acquired in buyout misses goal in rare disease studyTested in a condition known as ENPP1 deficiency, the treatment failed a trial goal that’s important to regulators, spurring doubts about its approval prospects.BioPharma Dive · 2mo ago↗ source